期刊文献+

CTR1和ATP7B在人肺腺癌细胞A549的表达及其与顺铂耐药的关系 被引量:1

Resistance to cisplatin is mediated by synergistic action of CTR1 and ATP7B in A549 cell line in vitro
下载PDF
导出
摘要 目的探讨人肺腺癌细胞株A549和肺腺癌顺铂耐药细胞株A549/DDP对顺铂的耐药机制。方法利用噻唑蓝法检测顺铂对A549/DDP及其亲代细胞株的细胞毒作用和生长曲线的影响,探讨A549/DDP细胞株凋亡敏感性的变化规律。采用Western blot检测该细胞株铜离子转运蛋白1(CTR1)、铜离子转运磷酸化ATP酶(ATP7B)及聚腺苷二磷酸-核糖聚合酶(PARP)剪切蛋白表达,分析A549细胞对顺铂耐药与CTR1、ATP7B及PARP剪切蛋白表达量的相关性。结果 A549/DDP较其亲代细胞株对顺铂引起的细胞毒性和凋亡敏感性下降;较其亲代细胞株A549/DDP中ATP7B表达增加,CTR1表达降低。结论人肺腺癌细胞株A549对顺铂耐药的产生与细胞凋亡敏感性降低有关,且细胞内ATP7B表达增加,CTR1表达降低,或可作为细胞对顺铂的增敏靶点。 Objective To study the mechanisms of cisplatin resistance of human lung adenocarcinoma cell lines A549 and A549/DDP. Methods Human lung adenocarcinoma A549 cells and a cisplatin-resistant derivative A549/DDP were treated with varying concentrations of cisplatin. The changes in cell growth,cytotoxicity and apoptosis were explored. Western blot was used to determine the expression of copper transporter 1(CTR1), copper transporting phosphorylated ATPase(ATP7B) and poly-ADP-ribose polymerase(PARP). The correlations of cisplatin resistance with CTR1, ATP7 B and PARP were analyzed. Results Compared to the A549 cells, the A549/DDP cells were less sensitive to cisplatin-induced cytotoxicity and apoptosis. ATP7 B expression increased but CTR1 expression decreased in the A549/DDP cells compared to the A 549 cells. Conclusions Our results demonstrate that reduced expression of the copper influx transporter CTR1 and overexpression of the copper efflux transporter ATP7 B are responsible for the resistance of A549/DDP cells to cisplatin. These results indicate well that the expression of ATP7 B and CTR1 may provide markers for chemoresistance and chemosensitivity, respectively, to cisplatin-based chemotherapy.
作者 罗霞 陈明伟
出处 《中国现代医学杂志》 CAS 北大核心 2016年第23期27-31,共5页 China Journal of Modern Medicine
关键词 顺铂耐药 肺癌A549细胞株 铜转运蛋白 铜离子转运磷酸化ATP酶 铜离子转运蛋白1 cisplatin-resistance lung adenocarcinoma cell line copper transporters 1 copper transporting phosphorylated ATPase
  • 相关文献

参考文献1

二级参考文献22

  • 1王中华,缪小平,谭文,张湘茹,徐兵河,林东昕.XRCC1单核苷酸多态与晚期非小细胞肺癌对铂类药物化疗敏感性的相关性[J].癌症,2004,23(8):865-868. 被引量:56
  • 2袁芃,缪小平,张雪梅,王中华,谭文,张湘茹,孙燕,徐兵河,林东昕.核苷酸切除修复系统基因遗传多态与晚期非小细胞肺癌患者铂类药物敏感性关系[J].癌症,2005,24(12):1510-1513. 被引量:46
  • 3史美祺,高长明,吴建中,曹海霞,冯继锋,许林,陆建伟,王丽.DNA修复酶XRCC1基因多态性与晚期肺癌化疗敏感性的关系研究[J].临床肿瘤学杂志,2006,11(8):575-578. 被引量:8
  • 4HILDEBRANDT M A,GU J,WU X.Pharmacogenomics of platinum-based chemotherapy in NSCLCU].Expert Opin Drug Metab Toxicol,2009,5(7):745-755.
  • 5KIYOHARA C,TAKAYAMA K,NAKANISHI Y.Association of genetic polymorphisms in the base excision repair pathway with lung cancer risk:a meta-analysis.[J].Lung Cancer,2006,54(3):267-283.
  • 6PARK S Y,HONC Y C,KIM J H,et al.Effect of ERCC1 polymorphisms and the modification by smoking on the survival of non-small cell lung cancer patientsUJ.Med Oncol,2006,23(4):489-498.
  • 7YU J J,LEE KB,MU C,et al.Comparison of two human ovarian carcinoma cell lines (A2780/ CP70 and MCAS) that are equally resistant to platinum,but differ at codon 118 of the ERCC1 gene[J].Int Oncol,2000,16(3):555-560.
  • 8RYU J S,VIGUIER J,PRAZ F.Genetic effect of ERCCl codon 118 polymorphism and confounding factors[J].Clin Cancer Res,2006,12(15):4784.
  • 9BENHAMOU S,SARASIN A.ERCC2/XPD gene polymorphisms and lung cancer:a HuGE review[J].Am J Epidemiol,2005,161(1):1-14.
  • 10PARK D J,STOEHLMACHER J,ZHANG W,et al.A Xeroderma pigmentosum group D gene polymorphism predicts clinical outcome to platinum-based chemotherapy in patients with advanced colorectal cancer[J].Cancer Res,2001,61(24):8654-8658.

共引文献10

同被引文献3

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部